Código QR (código de barras bidimensional)

Real-world outcomes of mepolizumab treatment in severe eosinophilic asthma patients - retrospective cohort study in Slovakia

Aims. Mepolizumab, a fully-humanized recombinant IgG1 kappa monoclonal antibody directed against IL-5, has shown improved asthma control and lung function in randomised controlled trials. The aim of this study was to evaluate real-world clinical experience in patients with severe eosinophilic asthma...

ver descrição completa

Na minha lista:
Principais autores: Milos Jesenak, Vaclav Vanecek, Martina Ondrusova, Veronika Urdova, Katarina Dostalova, Ludek Hochmuth
Formato: Artigo
Idioma:Inglês
Publicado em: Palacký University Olomouc, Faculty of Medicine and Dentistry 2023-09-01
coleção:Biomedical Papers
Assuntos:
severe eosinophilic asthma
exacerbations
mepolizumab
real world evidence
slovakia
Acesso em linha:https://biomed.papers.upol.cz/artkey/bio-202303-0008_real-world-outcomes-of-mepolizumab-treatment-in-severe-eosinophilic-asthma-patients-retrospective-cohort-stud.php
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados